Skip to main content
. 2014 Apr 7;111(16):5902–5907. doi: 10.1073/pnas.1320350111

Fig. 1.

Fig. 1.

Erbin expression is decreased during cardiac hypertrophy and heart failure. (A) Western blot analysis of Erbin protein levels in hearts from WT mice at baseline (Con) and after treatment with isoproterenol for 7 d (Iso). Densitometry results are expressed as Erbin:GAPDH ratio. Results represent mean ± SEM (n = 3). (B) Real-time PCR analysis of Erbin expression in hearts from WT mice after mild AAC or sham surgery. Results are expressed as Erbin:β-actin ratio, and represent mean ± SEM (n = 5). (C) Western blot analysis of Erbin in human heart biopsies from normal patients (Normal) and end-stage heart failure patients (DCM; dilated cardiomyopathy). Densitometry results are expressed as Erbin:β-actin ratio. Results represent mean ± SEM (n = 6). (D) Western blot analysis of Erbin in human heart biopsies from normal patients (Normal) and end-stage heart failure patients (HCM; hypertrophic cardiomyopathy). Densitometry results are expressed as Erbin:β-actin ratio. Results represent mean ± SEM (n = 5).